Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Nylon L.E. 0.45 ìm, 13 mm Dia.

Product Description
NYLON LOW EXTRACTABLES (LE)
• Superior to Nylon 66 membranes
• Nylon-LE is a unique unsupported Nylon membrane
• Does not release significant levels of extractables when in contact with acetonitrile
• Suitable for use with any HPLC sample or solvent
• The elimination of the polyester support in these Q-Fil filters, combined with the unique surface characteristics of this new membrane, eliminates many of the extractables found in Nylon membranes and results in a much cleaner filtrate

The Q-Fil range of Certified Syringe Filters set the new Quality standard for today’s laboratory syringe filters.
Manufactured from the highest quality medical grade high density polypropylene Q-Fil Certified Syringe Filters provide excellent chemical compatibility with acids, alcohols, bases, ethers, glycols, ketones and oils, with maximum operating temperatures of 135°C.
Every colour-coded filter is printed with the individual batch number, details of the membrane material and its pore size, on the outside rim of the filter, making them unique for traceability, GLPs and validation purposes.
Q-Fil Certified Syringe Filters -
• Manufactured in compliance with ISO 9001:2000 quality procedures.
• Are supplied with a Certificate of Analysis and Conformance to guarantee its batch to batch quality and performance.
• Are available in the most popular sizes, porosities and membrane types.
• Provide excellent resistance to all routinely used HPLC solvents.
• Have filter housings manufactured from high density medical grade polypropylene.
• Contain extremely low level of extractables for highly sensitive work.
• Luer connections fully comply with ISO 594-1.
• Filters are available with standard and 'Slim Tip' sized outlets.

To view Greyhound Chromatography's full range of Syringe Filrers please visit www.greyhound.com
Product Nylon L.E. 0.45 ìm, 13 mm Dia.
Company Greyhound Chromatography - Products
Price Request a quote
More Information View company product page
Catalog Number 40-100012
Quantity 100
Company Logo

Greyhound Chromatography - Products
Greyhound Chromatography and Allied Chemicals, 6 Kelvin Park, Birkenhead, Merseyside, United Kingdom CH41 1LT

Tel: +44 151 649 4000
Fax: +44 151 649 4001
Email: sales@greyhoundchrom.com



Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!